EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells

Lauren A Eanes, Mayar Eldeeb, Darrell Storholt, Yashomati M Patel iD

PLOS ONE · 03.04.2025 · 20 (4) · e0320020

DOI: 10.1371/journal.pone.0320020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.04.2025. Verfasst von Lauren A Eanes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of North Carolina at Greensboro, Greensboro, North Carolina, United States of America. Hauptthemen laut MEDLINE: Flavanones, Apoptosis, Tamoxifen, Mitochondria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the second leading cause of cancer deaths among women. While tamoxifen, a commonly used drug therapy in breast cancer patients, is effective, many patients acquire tamoxifen resistance. Therefore, it is essential to identify alternative or combination therapeutics for the treatment of breast cancer. Naringenin, a naturally occurring flavonoid, has been reported to elicit antioxidant, anti-proliferative, and pro-apoptotic effects in cancer cells. The current study aimed to identify the mechanism by which naringenin induces apoptosis in tamoxifen-resistant breast cancer cells. The present study demonstrated that naringenin induced an increase in ROS, resulting in oxidative stress, impaired mitochondrial function, and apoptosis in tamoxifen-resistant breast cancer cells. Our study reports that naringenin specifically increases mitochondrial superoxide anions and hydrogen peroxide production while also causing mitochondrial dysfunction. These studies provide novel evidence for the mechanism by which naringenin induces apoptosis in tamoxifen-resistant breast cancer cells and supports the use of naringenin as a therapeutic on breast cancer cells and drug-resistant cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesApoptosisTamoxifenMitochondriaDrug Resistance, NeoplasmReactive Oxygen SpeciesBreast NeoplasmsHumansMCF-7 CellsFemaleOxidative StressMembrane Potential, MitochondrialHydrogen Peroxide

Substanzen

FlavanonesnaringeninTamoxifenReactive Oxygen SpeciesHydrogen Peroxide

Autor:innen und Institutionen

  • Department of Biology, University of North Carolina at Greensboro, Greensboro, North Carolina, United States of America.

ORCID-Profile: Yashomati M Patel

Zitieren

APA

Eanes, L. A., Eldeeb, M., Storholt, D., & Patel, Y. M. (2025). Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells. PLOS ONE, 20(4), e0320020. https://doi.org/10.1371/journal.pone.0320020

Vancouver

Eanes LA, Eldeeb M, Storholt D, Patel YM. Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells. PLOS ONE. 2025;20(4):e0320020. doi:10.1371/journal.pone.0320020

BibTeX
@article{Eanes2025,
  author = {Eanes, Lauren A and Eldeeb, Mayar and Storholt, Darrell and Patel, Yashomati M},
  title = {Naringenin impairs mitochondrial function via ROS to induce apoptosis in tamoxifen resistant MCF-7 breast cancer cells},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {4},
  pages = {e0320020},
  doi = {10.1371/journal.pone.0320020}
}
Kostenlos starten →